FDA Grants Accelerated Approval to Sunvozertinib for Metastatic Non-Small Cell Lung Cancer with EGFR exon 20 Insertion Mutations By Ogkologos - July 25, 2025 306 0 Facebook Twitter Google+ Pinterest WhatsApp FDA also approved the Oncomine Dx Express Test as a companion diagnostic device Source RELATED ARTICLESMORE FROM AUTHOR ESMO Announces 2026 Society Award Recipients Honouring Excellence in Cancer Research, Care and Leadership Adjuvant Olaparib Continues to Improve Multiple Outcomes in Patients with Germline BRCA1/2-associated High-Risk HER2-negative EBC EMA Recommends Refusing the Marketing Authorisation for Copper (64Cu) Oxodotreotide MOST POPULAR 2022 ASCO Annual Meeting Research Round Up: New Research in Lung... September 15, 2022 How to Improve Cancer-Related Fatigue Using Exercise: Expert Perspectives June 21, 2023 Dwayne Johnson Sends Special “Moana” Message To 3-Yr-Old Battling Cancer. November 21, 2019 Mouse Study Links Immune Cells to Diarrhea Caused by Chemotherapy July 20, 2018 Load more HOT NEWS Significant 20-Year Benefit of 2 Years of Adjuvant Goserelin and Tamoxifen... 5-Year-Old Boy Battling Cancer Receives Dream Come True, Sworn In As... Longer PFS in Patients with Advanced Melanoma Treated with TILs than... Advancing Cancer Research as a Married Couple: “Your Stories” Podcast
